The pathological role of IL-18Rα in renal ischemia/reperfusion injury

[1]  A. Hamad,et al.  Antigen-Induced T Cell Death Is Regulated by CD4 Expression , 2001, International reviews of immunology.

[2]  K. Kinoshita,et al.  All-trans-retinoic acid suppresses interferon-γ and tumor necrosis factor-α; a possible therapeutic agent for rheumatoid arthritis , 2006, Rheumatology International.

[3]  Marek Ancukiewicz,et al.  Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. , 2005, Journal of the American Society of Nephrology : JASN.

[4]  H. Okamura,et al.  Cloning of a new cytokine that induces IFN-gamma production by T cells. , 1995, Nature.

[5]  S. Akira,et al.  Contrasting action of IL-12 and IL-18 in the development of dextran sodium sulphate colitis in mice. , 2003, Scandinavian journal of gastroenterology.

[6]  Seamus J. Martin,et al.  Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas , 1995, Nature.

[7]  K. Murphy,et al.  Bax membrane insertion during Fas(CD95)-induced apoptosis precedes cytochrome c release and is inhibited by Bcl-2 , 1999, Oncogene.

[8]  J. Bonventre,et al.  Ischemic acute renal failure: an inflammatory disease? , 2004, Kidney international.

[9]  J. Cardier,et al.  Differential effect of IL-18 on endothelial cell apoptosis mediated by TNF-alpha and Fas (CD95). , 2003, Cytokine.

[10]  K. Torigoe,et al.  Purification and Characterization of the Human Interleukin-18 Receptor* , 1997, The Journal of Biological Chemistry.

[11]  C. Trautwein,et al.  Severe hepatic injury in interleukin 18 (IL-18) transgenic mice: a key role for IL-18 in regulating hepatocyte apoptosis in vivo , 2004, Gut.

[12]  R. Safirstein,et al.  Cisplatin nephrotoxicity. , 2003, Seminars in nephrology.

[13]  G. Fantuzzi,et al.  Overview of interleukin‐18: more than an interferon‐γ inducing factor , 1998, Journal of leukocyte biology.

[14]  S. Holdsworth,et al.  T-bet deficiency attenuates renal injury in experimental crescentic glomerulonephritis. , 2008, Journal of the American Society of Nephrology : JASN.

[15]  C. Dinarello,et al.  Responses of IL-18- and IL-18 receptor-deficient pancreatic islets with convergence of positive and negative signals for the IL-18 receptor , 2006, Proceedings of the National Academy of Sciences.

[16]  R. Colvin,et al.  A pathophysiologic role for T lymphocytes in murine acute cisplatin nephrotoxicity. , 2006, Journal of the American Society of Nephrology : JASN.

[17]  I. Julkunen,et al.  IFN-α and IL-12 Induce IL-18 Receptor Gene Expression in Human NK and T Cells1 , 2000, The Journal of Immunology.

[18]  A. Burnett,et al.  A novel model of ischemia in renal tubular cells which closely parallels in vivo injury. , 2001, The Journal of surgical research.

[19]  K. Meyer,et al.  Cisplatin nephrotoxicity. , 1994, Mineral and electrolyte metabolism.

[20]  J. Lácha,et al.  Interleukin 18 (IL-18) upregulation in acute rejection of kidney allograft. , 2005, Immunology letters.

[21]  R. Wüthrich,et al.  Up-regulation of tubular epithelial interleukin-12 in autoimmune MRL-Fas(lpr) mice with renal injury. , 1997, Kidney international.

[22]  F. Belardelli,et al.  IFN‐α and IL‐18 exert opposite regulatory effects on the IL‐12 receptor expression and IL‐12‐induced IFN‐γ production in mouse macrophages: novel pathways in the regulation of the inflammatory response of macrophages , 2000, Journal of leukocyte biology.

[23]  K. Kinoshita,et al.  All-trans-retinoic acid suppresses interferon-gamma and tumor necrosis factor-alpha; a possible therapeutic agent for rheumatoid arthritis. , 2006, Rheumatology international.

[24]  C. Dinarello,et al.  Increased Cytokine Production in Interleukin-18 Receptor α-deficient Cells Is Associated with Dysregulation of Suppressors of Cytokine Signaling* , 2009, The Journal of Biological Chemistry.

[25]  P. Kiener,et al.  Fas (CD95) Induces Proinflammatory Cytokine Responses by Human Monocytes and Monocyte-Derived Macrophages12 , 2003, The Journal of Immunology.

[26]  Crafford A. Harris,et al.  Defective Interleukin (IL)-18–mediated Natural Killer and T Helper Cell Type 1 Responses in IL-1 Receptor–associated Kinase (IRAK)-deficient Mice , 1999, The Journal of experimental medicine.

[27]  J. Cardier,et al.  Differential effect of IL-18 on endothelial cell apoptosis mediated by TNF-α and Fas (CD95) , 2003 .

[28]  S. Holdsworth,et al.  Endogenous Tim-1 (Kim-1) promotes T-cell responses and cell-mediated injury in experimental crescentic glomerulonephritis. , 2012, Kidney international.

[29]  A. Warrens,et al.  Fas ligand exerts its pro‐inflammatory effects via neutrophil recruitment but not activation , 2007, Immunology.

[30]  H. Auchincloss,et al.  Role of CXC chemokine receptor 3 pathway in renal ischemic injury. , 2006, Journal of the American Society of Nephrology : JASN.

[31]  T. Tanimoto,et al.  Interleukin 18 enhances Fas ligand expression and induces apoptosis in Fas-expressing human myelomonocytic KG-1 cells. , 1997, Anticancer research.

[32]  T. Yano,et al.  Signaling through the interleukin-18 receptor α attenuates inflammation in cisplatin-induced acute kidney injury. , 2012, Kidney international.

[33]  S. Chadban,et al.  Macrophage-derived interleukin-18 in experimental renal allograft rejection. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[34]  H. Brady,et al.  Leukocytes, cell adhesion molecules and ischemic acute renal failure. , 1997, Kidney international.

[35]  K. Meldrum,et al.  IL-18 mediates proapoptotic signaling in renal tubular cells through a Fas ligand-dependent mechanism. , 2011, AJP - Renal Physiology.

[36]  S. Kaneko,et al.  Fas Ligand Has a Greater Impact than TNF-α on Apoptosis and Inflammation in Ischemic Acute Kidney Injury , 2012, Nephron Extra.

[37]  H. Kitaura,et al.  Effect of IL-12 on TNF-α-Mediated Osteoclast Formation in Bone Marrow Cells: Apoptosis Mediated by Fas/Fas Ligand Interaction1 , 2002, The Journal of Immunology.

[38]  K. Kinoshita,et al.  Blockade of IL-18 Receptor Signaling Delays the Onset of Autoimmune Disease in MRL-Faslpr Mice1 , 2004, The Journal of Immunology.

[39]  N. Ismail,et al.  The Interaction between IL-18 and IL-18 Receptor Limits the Magnitude of Protective Immunity and Enhances Pathogenic Responses following Infection with Intracellular Bacteria , 2011, The Journal of Immunology.

[40]  K. Meldrum,et al.  IL-18 neutralization ameliorates obstruction-induced epithelial-mesenchymal transition and renal fibrosis. , 2009, Kidney international.

[41]  Y. Nakanishi,et al.  Induction of apoptosis in ischemia-reperfusion model of mouse kidney: possible involvement of Fas. , 1998, Journal of the American Society of Nephrology : JASN.

[42]  J. Lukens,et al.  Increased Fas ligand expression of CD4+ T cells by HCV core induces T cell‐dependent hepatic inflammation , 2005, Journal of leukocyte biology.

[43]  S. Chadban,et al.  TLR4 activation mediates kidney ischemia/reperfusion injury. , 2007, The Journal of clinical investigation.

[44]  M. Caligiuri,et al.  Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. , 1999, Journal of immunology.

[45]  B. Padanilam,et al.  Poly(ADP-ribose) polymerase-mediated cell injury in acute renal failure. , 2005, Pharmacological research.

[46]  A. Ortiz,et al.  Nephrology Dialysis Transplantation the Fas Ligand/fas System in Renal Injury Fasl and Fas Leukocytes and Intrinsic Renal Cells ( Table 1). Murine , 2022 .